Glucocorticoid receptor
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Glucocorticoid receptor as ChEMBL target CHEMBL3368, mapped to UniProt P06536. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why Glucocorticoid receptor matters
Glucocorticoid receptor is reviewed as Glucocorticoid receptor (UniProt P06536); the current evidence base includes 13 approved drugs, 399 compounds, and 163 assays, with lead potency reaching pChEMBL 10.0.
Glucocorticoid receptor Sequence length is 795 aa.
Review this target as Glucocorticoid receptor, mapped to UniProt P06536. Sequence length is 795 aa.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 13 approved drugs, 399 compounds, and 163 assays for this target. The dominant activity type is IC50. CHEMBL3666814 is the current potency anchor at pChEMBL 10.0.
Use CHEMBL3666814 as the tractability anchor when discussing potency (pChEMBL 10.0).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why Glucocorticoid receptor matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract behind UniProt P06536, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL3666814
|
10.0 | IC50 | — |
|
|
No preferred name
CHEMBL4072756
|
9.8 | IC50 | Clinical |
|
|
No preferred name
CHEMBL1473
|
9.8 | IC50 | Approved |
|
|
No preferred name
CHEMBL4863316
|
9.8 | IC50 | — |
|
|
No preferred name
CHEMBL433586
|
9.7 | EC50 | — |
Approved Drugs
| Structure | Compound | First Approval |
|---|---|---|
|
|
MIFEPRISTONE
CHEMBL1276308
|
2000 |
|
|
BUDESONIDE
CHEMBL1370
|
1994 |
|
|
FLUTICASONE PROPIONATE
CHEMBL1473
|
1990 |
|
|
CLOBETASOL PROPIONATE
CHEMBL1159650
|
1985 |
|
|
BETAMETHASONE DIPROPIONATE
CHEMBL1200384
|
1975 |
|
|
DEXAMETHASONE
CHEMBL384467
|
1958 |
|
|
PREDNISOLONE
CHEMBL131
|
1955 |
|
|
HYDROCORTISONE
CHEMBL389621
|
1952 |